Apellis Pharmaceuticals, Inc. (APLS) Social Stream



Apellis Pharmaceuticals, Inc. (APLS): $37.25

0.79 (-2.08%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

APELLIS PHARMACEUTICALS INC (APLS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering APELLIS PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 12 $116 $28 $68.307 $39.67 72.19%
2021-11-12 12 $116 $28 $67.23 $39.67 69.47%
2021-11-17 11 $116 $28 $67.692 $39.67 70.64%
2021-11-24 12 $116 $28 $68.076 $39.67 71.61%
2021-11-29 12 $116 $28 $67.615 $39.67 70.44%
2021-12-15 13 $116 $28 $68.785 $39.67 73.39%
2022-01-05 13 $116 $28 $69 $39.67 73.93%
2022-01-11 13 $112 $28 $69.142 $39.67 74.29%
2022-01-26 13 $112 $34 $69.571 $39.67 75.37%
2022-03-02 13 $114 $34 $69.714 $39.67 75.73%
2022-03-16 13 $114 $34 $69.5 $39.67 75.2%
2022-03-17 13 $114 $34 $70.428 $39.67 77.53%
2022-03-22 13 $114 $34 $70.071 $39.67 76.63%
2022-04-04 12 $114 $34 $70.23 $39.67 77.04%
2022-04-14 12 $114 $34 $70.23 $39.67 77.04%
2022-04-19 12 $114 $34 $70.076 $39.67 76.65%
2022-04-21 12 $114 $34 $70.307 $39.67 77.23%
2022-04-28 12 $114 $39 $70.692 $39.67 78.2%
2022-05-10 12 $102 $40 $69.923 $39.67 76.26%
2022-05-12 12 $102 $40 $70.23 $39.67 77.04%
2022-06-01 12 $102 $40 $70.384 $39.67 77.42%
2022-06-17 13 $102 $40 $69.642 $39.67 75.55%
2022-07-25 13 $102 $40 $72.266 $39.67 82.17%
2022-08-09 13 $113 $40 $74.2 $39.67 87.04%
2022-08-13 13 $113 $40 $74.333 $39.67 87.38%
2022-08-24 13 $113 $40 $75.733 $39.67 90.91%
2022-09-06 13 $113 $40 $76.4 $39.67 92.59%
2022-10-04 13 $113 $40 $78.769 $39.67 98.56%
2022-10-17 13 $113 $40 $78.153 $39.67 97.01%
2022-10-21 13 $123 $40 $78.923 $39.67 98.95%
2022-11-04 13 $123 $40 $78.692 $39.67 98.37%
2022-11-08 13 $123 $40 $77.923 $39.67 96.43%
2022-11-10 13 $123 $40 $74.615 $39.67 88.09%
2022-11-18 13 $123 $40 $74.461 $39.67 87.7%
2023-01-03 13 $123 $40 $72.461 $39.67 82.66%
2023-01-26 12 $123 $40 $75.166 $39.67 89.48%
2023-02-16 12 $123 $40 $74.916 $39.67 88.85%
2023-02-21 14 $123 $47 $77.769 $39.67 96.04%
2023-02-22 14 $123 $51 $84.142 $39.67 112.1%
2023-02-23 14 $139 $51 $85.785 $39.67 116.25%
2023-02-24 14 $139 $51 $85.5 $39.67 115.53%
2023-03-09 14 $139 $51 $85.285 $39.67 114.99%
2023-03-13 14 $139 $51 $85.428 $39.67 115.35%
2023-04-17 14 $139 $58 $86.571 $39.67 118.23%
2023-04-24 14 $141 $58 $89.357 $39.67 125.25%
2023-05-02 14 $141 $58 $90.357 $39.67 127.77%
2023-05-05 14 $141 $58 $91.285 $39.67 130.11%
2023-05-08 14 $156 $58 $96.785 $39.67 143.98%
2023-05-09 14 $156 $76 $104.142 $39.67 162.52%
2023-06-06 14 $156 $76 $105 $39.67 164.68%
2023-07-17 14 $156 $76 $105.071 $39.67 164.86%
2023-07-21 14 $156 $40 $99.571 $39.67 151%
2023-07-31 14 $156 $40 $95.714 $39.67 141.28%
2023-08-01 14 $141 $32 $85.071 $39.67 114.45%
2023-08-02 14 $141 $32 $77.928 $39.67 96.44%
2023-08-03 14 $141 $32 $73.857 $39.67 86.18%
2023-08-07 14 $141 $29 $73.642 $39.67 85.64%
2023-08-29 14 $141 $29 $73 $39.67 84.02%
2023-09-08 13 $95 $29 $66.857 $39.67 68.53%
2023-09-15 13 $95 $29 $67.642 $39.67 70.51%

The Trend in the Analyst Price Target


APLS's average price target has moved down $7.27 over the prior 31 weeks.

APLS reports an average of 62.07% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-10-13 13 113 40 78.153 58.72 33.09%
2022-11-08 13 123 40 77.923 47.11 65.41%
2023-02-22 14 123 51 84.142 65.82 27.84%
2023-05-05 14 141 58 91.285 93.18 -2.03%
2023-08-01 14 141 32 85.071 24.22 251.24%

APLS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.69 8 1 4 0 0 13

The Trend in the Broker Recommendations


APLS's average broker recommendation rating worsened by 0.23 over the prior 15 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, APELLIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -6394.31% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, APELLIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 6180.15% of them.
  • APELLIS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 6062.69% of Pharmaceutical Products stocks.
  • APLS has a greater average analyst price target than 5886.72% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to APELLIS PHARMACEUTICALS INC are ZLAB, RDY, and BGNE.

What is the outlook for APLS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!